In the rapidly evolving digital health sector, an exit strategy is not just a formality; it is a critical part of a company’s growth plan. Whether through acquisition, merger, or IPO, exits are the moment where years of innovation, risk-taking, and execution translate into tangible returns for founders and investors.
In 2025, the exit landscape has shifted toward a more selective market, with mergers and acquisitions dominating the field and IPOs making a cautious but notable return. Startups that succeed in this environment share a set of characteristics that investors are watching closely. Understanding these can make the difference between an average outcome and a high-value exit.
The Exit Landscape in Digital Health
The first half of 2025 recorded 113 digital health exits, the majority through mergers and acquisitions. Venture-to-venture roll-ups and strategic consolidations are common as companies seek scale and operational efficiency. IPOs, while still rare, have begun re-emerging for companies with exceptional fundamentals, such as Hinge Health and Omada Health, both of which demonstrated profitability, robust growth, and strong retention rates prior to going public.
Investors are also particularly interested in companies that deliver what some call the “productivity premium,” i.e., solutions that shorten care pathways, lower costs, and improve patient outcomes. Artificial intelligence is playing a key role in enabling these efficiencies, with acquirers seeking technologies that integrate seamlessly into existing systems and workflows.
Market, Product, and Execution: The Core Investor Lens
When evaluating a startup’s potential for IPO or acquisition, investors consistently return to three core pillars: market, product, and execution.
Market evaluation begins with the size and urgency of the problem being addressed. Investors want to see a clear value proposition supported by payer interest and evidence that the solution addresses a high-priority gap in healthcare delivery. Defensible market positioning is critical, whether through intellectual property, regulatory approval, or network effects.
Product strength comes from clinical validation and integration into existing healthcare workflows. A digital health product must demonstrate measurable ROI for customers, whether that’s reducing hospital readmissions, cutting administrative time, or improving patient engagement. Investors assess scalability, unique intellectual property, and the cost to switch away from the solution, as high switching costs tend to lock in customers.
Execution depends on the capability and adaptability of the leadership team. Investors look for evidence that the team can deliver consistently, respond to market shifts, and maintain operational excellence. In digital health, execution also includes compliance with complex regulatory requirements, building strong partnerships, and maintaining high ethical standards in data use. In general, leadership teams with a mix of industry expertise, operational skill, and resilience are better equipped to navigate regulatory complexity, competitive pressures, and evolving market demands.
Strong Fundamentals and Financial Health
Naturally, beyond market-product fit and leadership, financial performance is also a decisive factor in attracting investor interest. Investors analyze predictable revenue streams such as monthly or annual recurring revenue, as well as growth trends in customer acquisition and retention. Unit economics, including customer acquisition cost and lifetime value, must be favorable and scalable.
The size of the total addressable market is another valuation driver. Startups addressing large and expanding markets command higher valuations, particularly when they can demonstrate strong penetration in an initial segment with room to expand into others. Financial discipline is equally important. Investors favor companies with a low burn rate relative to growth, healthy margins, and a sufficient runway to weather industry shifts or macroeconomic headwinds.
Given the current environment where mergers and acquisitions dominate, investors prioritize financial resilience and a proven ability to generate consistent cash flow. For IPO candidates, profitability or a clear path to it is essential to win market confidence.
Leadership Experience and Founder Commitment
Data from an analysis by digital health investor Halle Tecco, co-founder of Rock Health, of 61 exited digital health startups reveals the outsized importance of leadership experience. Ninety-eight percent of CEOs in these companies had prior business experience, and 94% had held leadership roles before their current position. Nearly two-thirds had prior startup experience, which suggests that the challenges of scaling a company to an exit benefit from battle-tested leadership.
The timeline to exit further emphasizes the need for long-term commitment. Acquisitions took an average of 9.5 years, while the time to IPO spanned nearly 12 years. This underlines that building a digital health company to the point of a high-value exit is a marathon, not a sprint.
Consistency in leadership also matters. In 67% of cases, founders remained in the CEO role through the exit, a sign that continuity of vision and strategic direction can be a valuable asset in negotiations and integration processes.
Why These Areas Matter Now and Moving Forward
The combination of a validated market and product, strong financial fundamentals, and experienced leadership provides investors with confidence that a digital health company can make a successful exit. These factors reduce uncertainty and signal that the company can thrive under new ownership or public scrutiny. They also position the startup to attract multiple potential acquirers or a favorable market reception if going public.
In today’s selective investment climate, exit readiness is about more than just growth, but about building a business that is strategically, financially, and operationally attractive. This requires long-term planning, disciplined execution, and a clear alignment between the company’s mission and the realities of the healthcare market. For founders, the path to a high-value exit in digital health begins long before acquisition talks or IPO roadshows. It requires building a business that excels in three critical areas: addressing a real market need with a clinically validated and scalable product, maintaining strong financial discipline and predictable revenue streams, and leading with an experienced, resilient team committed to the long haul.